IQGAP1 Is Important for Activation of Caspase-1 in Macrophages and Is Targeted by Yersinia pestis Type III Effector YopM
Open Access
- 29 August 2014
- journal article
- Published by American Society for Microbiology in mBio
- Vol. 5 (4) , e01402-14-14
Abstract
YopM is a leucine-rich repeat (LRR)-containing effector in several Yersinia species, including Yersinia pestis and Y. pseudotuberculosis . Different Yersinia strains encode distinct YopM isoforms with variable numbers of LRRs but conserved C-terminal tails. A 15-LRR isoform in Y. pseudotuberculosis YPIII was recently shown to bind and inhibit caspase-1 via a YLTD motif in LRR 10, and attenuation of YopM − YPIII was reversed in mice lacking caspase-1, indicating that caspase-1 inhibition is a major virulence function of YopM YPIII . To determine if other YopM proteins inhibit caspase-1, we utilized Y. pseudotuberculosis strains natively expressing a 21-LRR isoform lacking the YLTD motif (YopM 32777 ) or ectopically expressing a Y. pestis 15-LRR version with a functional (YopM KIM ) or inactivated (YopM KIM D 271 A) YLTD motif. Results of mouse and macrophage infections with these strains showed that YopM 32777 , YopM KIM , and YopM KIM D 271 A inhibit caspase-1 activation, indicating that the YLTD motif is dispensable for this activity. Analysis of YopM KIM deletion variants revealed that LRRs 6 to 15 and the C-terminal tail are required to inhibit caspase-1 activation. YopM 32777 , YopM KIM , and YopM KIM deletion variants were purified, and binding partners in macrophage lysates were identified. Caspase-1 bound to YopM KIM but not YopM 32777 . Additionally, YopM KIM bound IQGAP1 and the use of Iqgap1 −/− macrophages revealed that this scaffolding protein is important for caspase-1 activation upon infection with YopM − Y. pseudotuberculosis . Thus, while multiple YopM isoforms inhibit caspase-1 activation, their variable LRR domains bind different host proteins to perform this function and the LRRs of YopM KIM target IQGAP1, a novel regulator of caspase-1, in macrophages. IMPORTANCE Activation of caspase-1, mediated by macromolecular complexes termed inflammasomes, is important for innate immune defense against pathogens. Pathogens can, in turn, subvert caspase-1-dependent responses through the action of effector proteins. For example, the Yersinia effector YopM inhibits caspase-1 activation by arresting inflammasome formation. This caspase-1 inhibitory activity has been studied in a specific YopM isoform, and in this case, the protein was shown to act as a pseudosubstrate to bind and inhibit caspase-1. Different Yersinia strains encode distinct YopM isoforms, many of which lack the pseudosubstrate motif. We studied additional isoforms and found that these YopM proteins inhibit caspase-1 activation independently of a pseudosubstrate motif. We also identified IQGAP1 as a novel binding partner of the Yersinia pestis YopM KIM isoform and demonstrated that IQGAP1 is important for caspase-1 activation in macrophages infected with Yersinia . Thus, this study reveals new insights into inflammasome regulation during Yersinia infection.Keywords
This publication has 41 references indexed in Scilit:
- Caspase-11 stimulates rapid flagellin-independent pyroptosis in response to Legionella pneumophilaProceedings of the National Academy of Sciences, 2013
- IQGAP1 and its binding proteins control diverse biological functionsCellular Signalling, 2012
- IQGAP1 in microbial pathogenesis: Targeting the actin cytoskeletonFEBS Letters, 2011
- The C-Terminal Tail of Yersinia pseudotuberculosis YopM Is Critical for Interacting with RSK1 and for VirulenceInfection and Immunity, 2010
- A Yersinia Effector Protein Promotes Virulence by Preventing Inflammasome Recognition of the Type III Secretion SystemCell Host & Microbe, 2010
- Innate Immune Detection of Bacterial Virulence Factors Via the NLRC4 InflammasomeJournal of Clinical Immunology, 2010
- The InflammasomesCell, 2010
- Pyroptosis: host cell death and inflammationNature Reviews Microbiology, 2009
- Recognition of microorganisms and activation of the immune responseNature, 2007
- The type III secretion injectisomeNature Reviews Microbiology, 2006